Back to search

Article

OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate

2023-06-07

Abstract excerpt

<h4>Background</h4> The COVID-19 pandemic created unprecedented pressure on healthcare services. This study aimed to investigate if disease-modifying anti-rheumatic drug (DMARD) safety monitoring was affected during the COVID-19 pandemic. <h4>Methods</h4> A population-based cohort study was conducted with the approval of NHS England, using the OpenSAFELY platform to access electronic health record data from 24·2 m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e7e0af5-8cb1-5469-9d6a-928d7919a8fc
DOI
10.1101/2023.06.06.23290826
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rateDOI 10.1101/2023.06.06.23290826
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYSemantic proximity
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studySemantic proximity
Assessment of Impact of the COVID-19 Pandemic from the Perspective of Patients with Rheumatic and Musculoskeletal Diseases in Europe: Results from the REUMAVID Study (Phase 1)Semantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients’ primary care records in situ using OpenSAFELYSemantic proximity
How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity
Evaluating Nirmatrelvir-Ritonavir (Paxlovid®) in Outpatient COVID-19 Treatment: Safety, Tolerability, and Adherence Insights from Primary Healthcare ClinicsSemantic proximity
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large State-wide Health System During the Pandemic in 2020Semantic proximity
Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity
FOLIC ACID AND METHOTREXATE USE AND THEIR ASSOCIATION WITH COVID-19 DIAGNOSIS AND MORTALITY: AN ANALYSIS FROM THE UK BIOBANKSemantic proximity
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity
Use of molnupiravir: a Danish nationwide drug utilization studySemantic proximity
Select a neighboring publication to make it the new centre.